TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.

PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...

Pfizer and Arvinas' experimental breast cancer treatment failed to delay the progression of the disease in a broader group of ...

An experimental breast cancer treatment co-developed by Pfizer and Arvinas significantly improved the time some patients ...

Women with breast cancer who receive chemotherapy experienced a lasting decline in physical health, a new study found.

After a long period of annual declines, breast cancer mortality rates for women younger than 40 and older than 74 have ...

Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...

A father-of-three who had cancerous breast tissue removed said he feels "complete" again after getting a realistic "3D" ...

A father-of-three who had his right breast removed due to cancer finally feels “complete” again after getting a realistic 3D ...

The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...

Individuals with transportation insecurity appeared 41% less likely to undergo breast cancer screening than those without transportation difficulties, according to results of a cohort study. Alexa L.

A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.